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Modifications of mRNAs can have a profound effect on cellular function and differentiation. In this issue of
Cell Stem Cell, Batista et al. (2014) describe fundamental parameters of N6-methyl-adenosine modification
of mRNAs in embryonic stem cells and provide strong evidence that modification plays a role in exit from
pluripotency toward differentiation.Epigenetic modifications associated with
the DNA genome that regulate gene
expression are well described. Interest-
ingly, an analogous phenomenon in
RNA—N6-methyl-adenosine (m6A) modi-
fications—has recently begun to enter
the limelight. While the presence of m6A
in mRNA was first described 40 years
ago, advances in m6A antibodies and
sequencing technology have revealed
important parameters of this modification
(Dominissini et al., 2012). m6A modifica-
tions have been found in multiple eukary-
otes and viruses and can occur on both
mRNAs and noncoding RNAs. The meth-
yltransferases METTL3 and METTL14, in
conjunction with the mammalian splicing
regulator WTAP, form a complex to add
m6A to target transcripts (Liu et al.,
2014). The m6A modification can also be
reversed by demethylases such as FTO
and ALKBH5, whose altered expression
has detrimental effects on cells and
is associated with several pathological
conditions including obesity, cancer, and
developmental defects (Jia et al., 2011;
Zheng et al., 2013). Control of multiple as-
pects of the mRNA life cycle has been
attributed to m6A modification, but its
best characterized role to date is in
mRNA turnover. YTH domain family
proteins can recognize m6A-modified
mRNAs and relocalize them to cellular
sites of decay (Wang et al., 2014a).
Because of its dynamic nature, m6A-
mediated transcript regulation could
prove to be indispensable for stem cells,
which must have quick and coordinated
responses to environmental cues.
In this issue of Cell Stem Cell, Batista
et al. (2014) utilized global sequence ana-
lyses of mRNAs immunoprecipitated with
an m6A RNA-specific antibody to define
the mRNA methylome in mouse and hu-
man embryonic stem cells (ESCs). Inter-esting factors encoded by m6A -modified
mRNAs include multiple core pluripo-
tency factors and transcripts involved
in development and the cell cycle. In
addition, m6A modifications in mouse
and human ESCs were frequently found
near stop codons, at the beginning of 30
untranslated regions (UTRs), and in long
internal exons, indicating that m6A site
preference may be tied to functional roles
in regulating the RNA life cycle, as
described previously in somatic cells
(Meyer et al., 2012). Unmodified and
m6A transcripts had comparable rates of
transcription, but methylated RNAs had
shorter half-lives and reduced translation
efficiencies. This phenotype signifies a
prominent role for m6A in ESC RNA turn-
over in accordance with recent findings
in stem and somatic cells (Liu et al.,
2014; Wang et al., 2014a, 2014b).
The authors used gene editing to
completely knock out Mettl3 in mESCs
to determine the effects of reducing m6A
modifications of mRNA in stem cells.
Strikingly, the Mettl3 KO cells showed
improved self-renewal and proliferation,
but their ability to differentiate was signif-
icantly reduced compared to wild-type
mESCs. Knockdown ofMETTL3 in hESCs
produced similar results. These findings
contrast with a recent paper in which
Mettl3 and Mettl14 knockdowns in
mESCs led to decreased self-renewal
(Wang et al., 2014b), indicating a need
for further investigation to discern the full
effects of m6A dynamics in stem cells.
Comparison of the Mettl3 KO and wild-
type mESCs revealed a global loss of
m6A sites, including those found in plu-
ripotency genes such as Nanog. While
METTL3 is not the onlymethyltransferase,
it may specifically affect a subset of tran-
scripts associated with pluripotency. In
addition, teratomas derived from the KOCell Stem Cell 15,cells were poorly differentiated and re-
tained high expression of pluripotency
markers. These findings suggest that
RNA methylation may be the key that al-
lows stem cells to exit a proliferative
pluripotent state and enter a path of differ-
entiation (Figure 1).
In addition to m6A, recent evidence
suggests widespread and dynamic modi-
fication of mRNAs with pseudouridine
(Schwartz et al., 2014). Interestingly, mu-
tations in dyskerin, the enzyme respon-
sible for pseudouridine formation, have
been reported to be associated with
defects in hematopoietic stem cell differ-
entiation (Bellodi et al., 2013). Messenger
RNAs modified with pseudouridine and
5-methyl C, another mRNA modifica-
tion, efficiently reprogram somatic cells
to form induced pluripotent stem cells.
Thus mRNA modifications in general
appear to be tightly associated with cell
fate transitions associated with stem
cells.
The burning question of the underlying
molecular mechanism or mechanisms
responsible for the biological impact of
m6A mRNA modifications in stem cells
remains to be answered. At least three
major areas of posttranscriptional gene
expression appear to be in play. First,
the modification may influence the asso-
ciation of factors such as RNA binding
proteins and miRNAs with mRNA targets.
Since m6A modification occurs at a well-
defined consensus sequence (RRACU)
in all cell types analyzed to date, this
should assist in identifying nearby RNA
elements whose trans-acting factor in-
teractions may be influenced by the
modification. Second, the m6A modif-
ication could influence local mRNA struc-
ture because the N6 position is involved
in base triples and Hoogsteen base
pairs and has been previously shown toDecember 4, 2014 ª2014 Elsevier Inc. 669
Figure 1. m6A Modification of Transcripts Allows Stem Cells to Effectively ‘‘Open the Door’’
to Various Paths of Differentiation
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Previewsinfluence the thermodynamic stability of
RNA duplexes. Changes in mRNA folding
can reveal or mask regulatory elements
that influence the fate of a transcript.
Finally, m6A modifications could mark
mRNAs as having passed quality control
tests in the cell. Stem cells may be reluc-
tant to differentiate without this modifica-
tion on key transcripts. 30 UTR length and
termination codons are major parts of670 Cell Stem Cell 15, December 4, 2014 ª2mRNA surveillance pathways. Thus, the
strong bias for m6A modifications in the
30 UTR near stop codons of mature
mRNAs is suggestive of a role in mRNA
quality control.
In summary, the extensive work in
furthering the characterization of the
ESC mRNA methylome by Batista et al.
provides a strong foundation for experi-
ments to determine in-depth answers to014 Elsevier Inc.precisely how m6A modification influ-
ences stem cell fate. There are undoubt-
edly exciting times ahead in this area of
stem cell biology.REFERENCES
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